Dr. Arnold C. Cinman, M.D.
Urology (Urology Physician)
8635 W 3rd St, Suite 1w
Los Angeles, CA 90048
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 55
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 706
Licensed in California since 1981, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
CA license A37071 (first issued 1981; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
Medical groups
- Tower Urology Inc (13 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 706
- Services billed
- 50,300
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Injection, testosterone cypionate, 1 mg | 32,100 | 15 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,300 | 23 |
| Manual urinalysis test with examination using microscope, non-automated | 1,319 | 661 |
| Creatinine level to test for kidney function or muscle injury | 1,319 | 661 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,275 | 603 |
| Insertion of needle into vein for collection of blood sample | 739 | 454 |
| Psa (prostate specific antigen) measurement, total | 725 | 443 |
| Testosterone (hormone) level, total | 713 | 438 |
| Complete ultrasound scan of pelvis | 581 | 394 |
| Detection test by nucleic acid for organism, amplified probe technique | 455 | 32 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Los Angeles, CA | 483 |
| Finasteride Other prescribers in Los Angeles, CA | 246 |
| Dutasteride Other prescribers in Los Angeles, CA | 191 |
| Gemtesa (vibegron) Other prescribers in Los Angeles, CA | 80 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Los Angeles, CA | 46 |
| Dutasteride-Tamsulosin (dutasteride/tamsulosin hcl) | 35 |
| Cefuroxime (cefuroxime axetil) Other prescribers in Los Angeles, CA | 32 |
| Tadalafil | 30 |
| Potassium Citrate Er (potassium citrate) Other prescribers in Los Angeles, CA | 28 |
| Nitrofurantoin (nitrofurantoin macrocrystal) Other prescribers in Los Angeles, CA | 22 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 34 payments worth $4,691 in total to this clinician.
| Avyxa Pharma, LLC | $3,937 |
|---|---|
| Dendreon Pharmaceuticals LLC | $112 |
| Dornier Medtech America, Inc | $102 |
| Telix Pharmaceuticals | $100 |
| Janssen Biotech, Inc. | $89.94 |
| Pfizer Inc. | $83.93 |
| Sumitomo Pharma America, Inc. | $56.31 |
| Immunitybio, Inc. | $45.30 |
| Compensation for services other than consulting (speaking, faculty) | $2,000 |
|---|---|
| Travel and Lodging | $1,661 |
| Food and Beverage | $1,030 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Avyxa Pharma, LLC Sep 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,000 |
| Avyxa Pharma, LLC Sep 13, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $826 |
| Avyxa Pharma, LLC Sep 13, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $648 |
| Avyxa Pharma, LLC Sep 13, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $188 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,000 in research payments for these studies, mostly to the institutions running them.
- An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer-sponsored studies
Bayer HealthCare Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.